June 1, 2016 -
BioConnect and Suprema announced Suprema’s launch of the BioConnect Identity Platform today.
The BioConnect Identity Platform was developed by Suprema’s strategic partner in North America, BioConnect. The BioConnect Identity Platform provides an integration of Suprema’s biometric solutions with more than 20 leading access control systems in the global security market.
“With the BioConnect Identity Platform, BioConnect complements our goal of providing industry-leading biometric security solutions to the global market. The product is a ready-made bridge solution that provides easier integration of cutting-edge Suprema biometric technology together with a customer’s choice of leading access control systems,” said Young Moon, VP of Suprema.
“We are looking forward to providing the BioConnect Identity Platform to a more global security market and are excited to offer our customers a seamless and cost-effective way of adopting Suprema’s biometric security solutions.”
The BioConnect Identity Platform integrates the following leading access control systems with the Suprema biometric terminals; ACT ACTManage, AMAG Symmetry, Axis A1001, Brivo OnAir/OnSite, Genetec Security Center, IMRON IS2000, Lenel OnGuard, Open Options dnaFusion, Paxton Net2, Honeywell ProWatch, Honeywell WINPAK, RS2 AccessIT!, S2 Netbox, Software House CCURE 9000, Stanley SecureNET, Gallagher Command Centre and now PCSC LiNC-PLUS.
“As a Suprema partner we have experienced a lot of growth in the North American and UK markets due to its leadership and continued emphasis on producing biometric products of superior quality, versatility and range,” said Steve Greb, Strategic Director of Business Development at BioConnect. “We’re very excited to draw on Suprema’s impressive partner network and continue to build out our Quest for Rightful Identity on a global scale.”
Suprema will provide and support the BioConnect Identity Platform globally from June 1, 2016 onward.